Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses

Thomas H. Pulliam(University of Washington), Shailender Bhatia(University of Washington)

Journal for ImmunoTherapy of Cancer

October 1, 2024

10.1136/jitc-2024-009803

Cited by 11

Related Papers

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

|Clinical Cancer Research|2019|89